AU9425998A - Azetidinone derivatives for the treatment of hcmv infections - Google Patents
Azetidinone derivatives for the treatment of hcmv infectionsInfo
- Publication number
- AU9425998A AU9425998A AU94259/98A AU9425998A AU9425998A AU 9425998 A AU9425998 A AU 9425998A AU 94259/98 A AU94259/98 A AU 94259/98A AU 9425998 A AU9425998 A AU 9425998A AU 9425998 A AU9425998 A AU 9425998A
- Authority
- AU
- Australia
- Prior art keywords
- alkyl
- het
- aryl
- phenyl
- lower alkyl
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
- 206010011831 Cytomegalovirus infection Diseases 0.000 title abstract 2
- MNFORVFSTILPAW-UHFFFAOYSA-N azetidin-2-one Chemical class O=C1CCN1 MNFORVFSTILPAW-UHFFFAOYSA-N 0.000 title 1
- 125000000217 alkyl group Chemical group 0.000 abstract 8
- 125000004169 (C1-C6) alkyl group Chemical group 0.000 abstract 3
- 125000003118 aryl group Chemical group 0.000 abstract 3
- 125000001997 phenyl group Chemical group [H]C1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 abstract 3
- 150000001875 compounds Chemical class 0.000 abstract 2
- 125000000008 (C1-C10) alkyl group Chemical group 0.000 abstract 1
- 125000000041 C6-C10 aryl group Chemical group 0.000 abstract 1
- 108010016626 Dipeptides Proteins 0.000 abstract 1
- 239000002253 acid Substances 0.000 abstract 1
- 125000002252 acyl group Chemical group 0.000 abstract 1
- 125000003275 alpha amino acid group Chemical class 0.000 abstract 1
- 150000001408 amides Chemical class 0.000 abstract 1
- 125000000051 benzyloxy group Chemical group [H]C1=C([H])C([H])=C(C([H])=C1[H])C([H])([H])O* 0.000 abstract 1
- 125000003178 carboxy group Chemical group [H]OC(*)=O 0.000 abstract 1
- 125000000753 cycloalkyl group Chemical group 0.000 abstract 1
- 125000004185 ester group Chemical group 0.000 abstract 1
- 229910052739 hydrogen Inorganic materials 0.000 abstract 1
- 239000001257 hydrogen Substances 0.000 abstract 1
- 125000004435 hydrogen atom Chemical group [H]* 0.000 abstract 1
- -1 methoxy, ethoxy Chemical group 0.000 abstract 1
- 229910052757 nitrogen Inorganic materials 0.000 abstract 1
- 125000004433 nitrogen atom Chemical group N* 0.000 abstract 1
- QJGQUHMNIGDVPM-UHFFFAOYSA-N nitrogen group Chemical group [N] QJGQUHMNIGDVPM-UHFFFAOYSA-N 0.000 abstract 1
- 229910052760 oxygen Inorganic materials 0.000 abstract 1
- 150000003839 salts Chemical class 0.000 abstract 1
- 229910052717 sulfur Inorganic materials 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/20—Antivirals for DNA viruses
- A61P31/22—Antivirals for DNA viruses for herpes viruses
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D205/00—Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom
- C07D205/02—Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom not condensed with other rings
- C07D205/06—Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
- C07D205/08—Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with one oxygen atom directly attached in position 2, e.g. beta-lactams
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D205/00—Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom
- C07D205/02—Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom not condensed with other rings
- C07D205/06—Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
- C07D205/08—Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with one oxygen atom directly attached in position 2, e.g. beta-lactams
- C07D205/09—Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with one oxygen atom directly attached in position 2, e.g. beta-lactams with a sulfur atom directly attached in position 4
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- Epidemiology (AREA)
- Molecular Biology (AREA)
- Virology (AREA)
- Engineering & Computer Science (AREA)
- Biotechnology (AREA)
- Communicable Diseases (AREA)
- Oncology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US6155097P | 1997-10-07 | 1997-10-07 | |
| US60061550 | 1997-10-07 | ||
| PCT/CA1998/000952 WO1999018071A1 (en) | 1997-10-07 | 1998-10-06 | Azetidinone derivatives for the treatment of hcmv infections |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| AU9425998A true AU9425998A (en) | 1999-04-27 |
Family
ID=22036487
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AU94259/98A Abandoned AU9425998A (en) | 1997-10-07 | 1998-10-06 | Azetidinone derivatives for the treatment of hcmv infections |
Country Status (11)
| Country | Link |
|---|---|
| US (1) | US6239125B1 (enExample) |
| EP (1) | EP1021404B1 (enExample) |
| JP (1) | JP2001519328A (enExample) |
| AT (1) | ATE230725T1 (enExample) |
| AU (1) | AU9425998A (enExample) |
| CA (1) | CA2301548C (enExample) |
| DE (1) | DE69810651T2 (enExample) |
| DK (1) | DK1021404T3 (enExample) |
| ES (1) | ES2187063T3 (enExample) |
| PT (1) | PT1021404E (enExample) |
| WO (1) | WO1999018071A1 (enExample) |
Families Citing this family (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US7541357B2 (en) | 2004-07-15 | 2009-06-02 | Amr Technology, Inc. | Aryl- and heteroaryl-substituted tetrahydroisoquinolines and use thereof to block reuptake of norepinephrine, dopamine, and serotonin |
| KR100599876B1 (ko) * | 2004-08-31 | 2006-07-13 | 한국화학연구원 | 2-아릴메틸아제티딘 카바페넴 유도체 및 그의 제조방법 |
| US9156812B2 (en) | 2008-06-04 | 2015-10-13 | Bristol-Myers Squibb Company | Crystalline form of 6-[(4S)-2-methyl-4-(2-naphthyl)-1,2,3,4-tetrahydroisoquinolin-7-yl]pyridazin-3-amine |
| CA2760837C (en) * | 2009-05-12 | 2018-04-03 | Albany Molecular Research, Inc. | 7-([1,2,4]triazolo[1,5-.alpha.]pyridin-6-yl)-4-(3,4-dichlorophenyl)-1,2,3,4-tetrahydroisoquinoline and use thereof |
| JP5739415B2 (ja) * | 2009-05-12 | 2015-06-24 | ブリストル−マイヤーズ スクウィブ カンパニー | （Ｓ）−７−（［１，２，４］トリアゾロ［１，５−ａ］ピリジン−６−イル）−４−（３，４−ジクロロフェニル）−１，２，３，４−テトラヒドロイソキノリンの結晶形態およびその使用 |
| ES2446971T3 (es) * | 2009-05-12 | 2014-03-11 | Albany Molecular Research, Inc. | Tetrahidroisoquinolinas sustituidas con arilo, heteroarilo, y heterociclo y su uso |
| TWI838401B (zh) | 2018-09-12 | 2024-04-11 | 瑞士商諾華公司 | 抗病毒性吡啶并吡𠯤二酮化合物 |
| TWI867053B (zh) | 2019-09-26 | 2024-12-21 | 瑞士商諾華公司 | 抗病毒吡唑并吡啶酮化合物 |
Family Cites Families (12)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4680391A (en) | 1983-12-01 | 1987-07-14 | Merck & Co., Inc. | Substituted azetidinones as anti-inflammatory and antidegenerative agents |
| US5229381A (en) | 1983-12-01 | 1993-07-20 | Merck & Co., Inc. | Substituted azetidinones as anti-inflammatory and antidegenerative agents |
| NZ228600A (en) * | 1988-04-11 | 1992-02-25 | Merck & Co Inc | 1-(benzylaminocarbonyl)-4-phenoxy-azetidin-2-one derivatives |
| EP0377549B1 (en) | 1989-01-03 | 1998-12-09 | Marcos Y. Kleinerman | Remote measurement of physical variables with fiber optic systems |
| US5100880A (en) * | 1991-03-20 | 1992-03-31 | Merck & Co., Inc. | Novel betalactam elastase inhibitors containing phosphorous acid derivatives at the 4-position of the 2-azetidinone |
| US5104862A (en) * | 1991-03-20 | 1992-04-14 | Merck & Co., Inc. | Bethalactam elastase inhibitors containing phosphorous acid derivatives at the 4-position of the 2-azetidinone |
| GB2266527A (en) | 1992-03-17 | 1993-11-03 | Merck & Co Inc | Substituted azetidinones useful in the treatment of leukemia |
| GB9314350D0 (en) * | 1993-07-12 | 1993-08-25 | Zeneca Ltd | Armide derivatives |
| EP0804930A1 (en) * | 1994-03-23 | 1997-11-05 | Tokyo Tanabe Company Limited | Novel remedy for respiratory-tract viral disease |
| WO1997025047A1 (en) * | 1996-01-11 | 1997-07-17 | Smithkline Beecham Corporation | Novel cycloalkyl substituded imidazoles |
| JP2000505451A (ja) * | 1996-02-21 | 2000-05-09 | ダーウィン・ディスカバリー・リミテッド | キノロン類およびこれらの治療的使用 |
| JPH09255547A (ja) * | 1996-03-22 | 1997-09-30 | Kao Corp | 皮膚外用剤 |
-
1998
- 1998-10-06 AU AU94259/98A patent/AU9425998A/en not_active Abandoned
- 1998-10-06 US US09/167,142 patent/US6239125B1/en not_active Expired - Lifetime
- 1998-10-06 WO PCT/CA1998/000952 patent/WO1999018071A1/en not_active Ceased
- 1998-10-06 ES ES98947255T patent/ES2187063T3/es not_active Expired - Lifetime
- 1998-10-06 DK DK98947255T patent/DK1021404T3/da active
- 1998-10-06 AT AT98947255T patent/ATE230725T1/de active
- 1998-10-06 EP EP98947255A patent/EP1021404B1/en not_active Expired - Lifetime
- 1998-10-06 PT PT98947255T patent/PT1021404E/pt unknown
- 1998-10-06 CA CA002301548A patent/CA2301548C/en not_active Expired - Fee Related
- 1998-10-06 JP JP2000514883A patent/JP2001519328A/ja not_active Ceased
- 1998-10-06 DE DE69810651T patent/DE69810651T2/de not_active Expired - Lifetime
Also Published As
| Publication number | Publication date |
|---|---|
| EP1021404B1 (en) | 2003-01-08 |
| JP2001519328A (ja) | 2001-10-23 |
| CA2301548A1 (en) | 1999-04-15 |
| DK1021404T3 (da) | 2003-03-24 |
| WO1999018071A1 (en) | 1999-04-15 |
| DE69810651T2 (de) | 2003-08-21 |
| ATE230725T1 (de) | 2003-01-15 |
| PT1021404E (pt) | 2003-04-30 |
| EP1021404A1 (en) | 2000-07-26 |
| DE69810651D1 (de) | 2003-02-13 |
| ES2187063T3 (es) | 2003-05-16 |
| CA2301548C (en) | 2005-05-17 |
| US6239125B1 (en) | 2001-05-29 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ATE159945T1 (de) | Beta-aminoalkyl und beta-n- peptidylaminoalkylborsäure | |
| ES8802220A1 (es) | Procedimiento para la obtencion de amidas de acidos benzoheterociclilalcanoicos. | |
| CA2140598A1 (en) | Prolineamide derivatives | |
| CA2224438A1 (en) | Vinyl-pyrrolidinone cephalosporins with basic substituents | |
| EP0592677A4 (en) | -g(b)-lactam compound and cephem compound, and production thereof | |
| HK5684A (en) | Penicillin derivatives | |
| ZA934997B (en) | Use of 2-(N-(2-aminoethyl)amino)acetic acid derivatives | |
| TW368501B (en) | 7-(2-aminoethyl)-benzothiazolones | |
| CA2203237A1 (en) | Aminotetrazole derivatives useful as nitric oxide synthase inhibitors | |
| AU9426098A (en) | Azetidinone derivatives for the treatment of hcmv infections | |
| AU9425998A (en) | Azetidinone derivatives for the treatment of hcmv infections | |
| AU9426198A (en) | Azetidinone derivatives for the treatment of hcmv infections | |
| DE69132707D1 (de) | N-Acyldipeptide, und pharmazeutische Präparate davon | |
| DE69408888D1 (de) | Neue reaktive Thiophosphat-Derivate von Thia(dia)zol-Essigsäure und Verfahren zur Herstellung derselben | |
| NO975499L (no) | Form III krystallinsk (R-(R*,R*)-2(4-fluorfenyl)-<beta>-<delta>-dihydroksy-(1-metyl-etyl)-3-fenyl-4-(fenylamino)karbonyl)-1H-pyrrol-1-heptansyre-hemi-kalsiumsalt | |
| EP0431520A3 (en) | Heterocyclic acyl aminodiol beta-amino acid derivatives | |
| MX9708422A (es) | Esteres de carbapenemas. | |
| NZ331180A (en) | Specific immunophilin ligands with indole structure as antiasthmatics and immunosuppressants | |
| ZA909305B (en) | Heterocyclic carboxylic acids | |
| DE50000905D1 (de) | Verfahren zur Herstellung von N-Acyl-aminosäureestern und N-Acyl-aminoacetalen | |
| DE69427100D1 (de) | Herstellung von Beta-lactamverbindungen und Zwischenprodukte | |
| HUP0203921A2 (hu) | Diazepin-karboxamid-származékok, eljárás a vegyületek előállítására, ezeket tartalmazó gyógyszerkészítmények és alkalmazásuk | |
| CA2359031A1 (en) | Thiazolidinone or oxazolidinone derivatives for treatment of ulcerative disease |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| MK6 | Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase |